Clinical Observation on Combined Therapy of Atorvastatin Calcium and Xuezhikang on Lipid-lowering

DOI

10.2991/msmee-17.2017.26How to use a DOI?

Keywords

Lipid-lowering Therapy, Clinical Observation, Atorvastatin Calcium

Abstract

With the improvement of economic living standards and changes in people's lifestyles and eating habits, in recent years to atherosclerosis-based ischemic cardiovascular disease (including coronary heart disease and ischemic stroke) significantly increased the incidence, Hyperlipidemia is one of the risk factors for arteriosclerosis, coronary heart disease trigger factor, lower blood lipids help reduce the incidence of cardiovascular and cerebrovascular events and mortality. At present, a variety of statins lipid-lowering drug prices are more expensive, many patients difficult to adhere to long-term use. This study investigated the effects of atorvastatin and Xuezhikang capsules on lipid lowering in elderly patients with hyperlipidemia.

Copyright

© 2017, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Min Chen
PY  - 2017/05
DA  - 2017/05
TI  - Clinical Observation on Combined Therapy of Atorvastatin Calcium and Xuezhikang on Lipid-lowering
BT  - Proceedings of the 2017 2nd International Conference on Materials Science, Machinery and Energy Engineering (MSMEE 2017)
PB  - Atlantis Press
SP  - 129
EP  - 132
SN  - 2352-5401
UR  - https://doi.org/10.2991/msmee-17.2017.26
DO  - 10.2991/msmee-17.2017.26
ID  - Chen2017/05
ER  -